Mortality after surgery for benign prostate hyperplasia : a nationwide cohort study

Show full item record



Permalink

http://hdl.handle.net/10138/346126

Citation

Salmivalli , A , Ettala , O , Boström , P J & Kytö , V 2022 , ' Mortality after surgery for benign prostate hyperplasia : a nationwide cohort study ' , World Journal of Urology , vol. 40 , no. 7 , pp. 1785-1791 . https://doi.org/10.1007/s00345-022-03999-0

Title: Mortality after surgery for benign prostate hyperplasia : a nationwide cohort study
Author: Salmivalli, Alisa; Ettala, Otto; Boström, Peter J.; Kytö, Ville
Contributor organization: Clinicum
Department of Public Health
Date: 2022-07
Language: eng
Number of pages: 7
Belongs to series: World Journal of Urology
ISSN: 0724-4983
DOI: https://doi.org/10.1007/s00345-022-03999-0
URI: http://hdl.handle.net/10138/346126
Abstract: Purpose To investigate postoperative mortality rates and risk factors for mortality after surgical treatment of benign prostate hyperplasia (BPH). Methods All patients who underwent partial prostate excision/resection from 2004 to 2014 in Finland were retrospectively assessed for eligibility using a nationwide registry. Procedures were classified as transurethral resection of the prostate (TURP), laser vaporization of the prostate (laser), and open prostatectomy. Univariable and multivariable regression were used to analyze the association of age, Charlson comorbidity index (CCI), operation type, annual center operation volume, study era, atrial fibrillation, and prostate cancer diagnosis with 90 days postoperative mortality. Results Among the 39,320 patients, TURP was the most common operation type for lower urinary tract symptoms in all age groups. The overall 90 days postoperative mortality was 1.10%. Excess mortality in the 90 days postoperative period was less than 0.5% in all age groups. Postoperative mortality after laser operations was 0.59% and 1.16% after TURP (p = 0.035). Older age, CCI score, and atrial fibrillation were identified as risk factors for postoperative mortality. Prostate cancer diagnosis and the center's annual operation volume were not significantly associated with mortality. The most common underlying causes of death were malignancy (35.5%) and cardiac disease (30.9%). Conclusion Elective urologic procedures for BPH are generally considered safe, but mortality increases with age. Laser operations may be associated with lower mortality rates than the gold standard TURP. Thus, operative risks and benefits must be carefully considered on a case-by-case basis. Further studies comparing operation types are needed.
Subject: Benign prostate hyperplasia
Transurethral resection of prostate
Laser vaporization
Open simple prostatectomy
URINARY-TRACT SYMPTOMS
MORBIDITY
CANCER
3126 Surgery, anesthesiology, intensive care, radiology
Peer reviewed: Yes
Rights: cc_by
Usage restriction: openAccess
Self-archived version: publishedVersion


Files in this item

Total number of downloads: Loading...

Files Size Format View
Salmivalli2022_ ... yAfterSurgeryForBenign.pdf 421.3Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record